Trial Profile
A prospective study of Safinamide in patients with Parkinson's Disease with motor fluctuations and freezing of gait
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Safinamide (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 29 Jul 2018 New trial record
- 19 Jun 2018 Results presented at the 4th Congress of the European Academy of Neurology